CereVasc raised $43.9 million in series A financing to support the development of a minimally invasive alternative for hydrocephalus, a condition sometimes called "water on the brain."

A recent survey suggests that dentists should engage with patients on social media to share educational content, but that doesn't mean patients want to see images from bloody procedures in their newsfeeds.

Like many of its peers, including Boston Scientific and Johnson & Johnson, Medtronic's business has been impacted by procedure deferrals as healthcare systems around the world have deferred most elective surgery to focus on COVID-19.

The $4.7 million loan under the paycheck protection program comes after the Billerica, MA-based company furloughed about one-third of its workforce because of sharp declines in procedures.

The robotic surgery pioneer beat Wall Street estimates and saw an increase in revenue before COVID-19 cases began to rise in the United States.

As more medical device companies update 2020 guidance, the business impact of COVID-19 becomes somewhat clearer.

Boston Scientific is recalling 6,130 Imager II 5F Angiographic Catheters because there is a potential for the catheter tip to become detached during a patient procedure or during procedure preparation. FDA had received nine injury reports for this...

The weight-loss surgery specialist said alternatives could include equity or debt financing; a sale of the company; a business combination; or a merger or reverse merger with another party.

An expert discusses how organ transplants are being handled during the coronavirus pandemic.

The custom orthopedics company said it was furloughing 80 employees because of sharp declines in elective procedures resulting from the coronavirus pandemic. The news comes as President Trump announced he was pushing to ‘reopen’ the economy by...